1Blackstein M,Vogel CL,Ambinder R,et al.Gemcetabine as first-line therapy in patients with metastatic breast cancer:a phase Ⅱ trail[J].Oncology,2002,62(1):2-8.
2Heinemann V.Gemcitabline plus cisplatin for the treatment of metastatic breast cancer[J].Clin Breast Cancer,2002,62(1):2-8.
7Mohran TZ.Gemcitabine and Cisplatin combination chemotherapy as a first-line treatment in patients with metastatic breast cance[J].J Egypt Nat1 Canc Inst.2004,16(1):8-14.
8Nagourney RA,Link JS,Blitzer J,et al.Gemcitabline plus cisplatin repeating doublet therapy in previously treated,relapsed breast cancer patients[J].J Clin Oncol,2000,18(11):224-2249.
1[1]Heinemann V. Gemcitabine plus cisplatin for the treatment of metastatic breast cancer[ J]. Clin Breast Cancer,2002,3 (Suppl 1 ): S24-S29.
2[2]Seidman AD. Gemcitabine as single-agent therapy in the management of advanced breast cancer [ J ]. Oncology, 2001,15(2) (Suppl 3): 11-14.
3[3]Jurga L,Misurova E, Kovac V, et al. The role of cisplatin in chemotherapy of advanced breast cancer[J]. Neoplasma, 1994,41 ( 6 ) :347-352.
4[4]Carmichael J, Walling J. Advanced breast cancer:investigational role of gemcitabine[ J]. Eur J Cancer, 1997,33( Suppl 1 ): S27-S31.
5[5]Pegram MD, Lipton A, Hayes DF, et al. Phase Ⅱ study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment [ J ]. J Clin Oncol, 1998, 16(8) :2659-2671.
6[6]Ray-Coquard Ⅰ, Biron P, Bachelot T, et al. Vinorelbine and cisplatin ( CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline-and/or paclitaxelcontaining regimens[ J]. Cancer, 1998 ,82 ( 1 ): 134-140.
7[7]Vassilomanolakis M, Koumakis G, Barbounis V, et al.Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines [ J ]. Ann Oncol, 2000,11(5) :1155-1160.
8[8]Moorsel CJ, Veerman G, Bergman AM, et al. Combination chemotherapy studies with gemcitabine[ J]. Semin Oncol, 1997,2,4(2): S7-S23.
9[9]Nagourney RA, Evans SS, Makalinao AJ, et al. Gemcitabine activity in primary cultures of human caner ( Abstract 2161 )[J]. Proc Am Assoc Cancer Res, 1996,37: 318.
10Spielmann M, Llombart Cussac A, Kalla S, et al. Single-agent gemcitabine is active in previously treated metastatic breast cancer[J].Oncology ,2001,60(4): 303-307.
2[6]Seidman AD.Gemeitabine as single-agent therapy in the management of advanced breast cancer[J].Oncology,2001,15 (2)(Suppl 3):11-14
3[8]Mohran TZ.Gemcitabine and cisplatin combination chemotherapy as a first-line treatment in patients with metastatic breast cancer[J].J Egypt Natl Canc Inst,2004,16(1):8-14
4[9]Nagoumey RA,Link JS,Blitzer J,et al.Gemcitabine plus cisplatin repeating doublet therapy in previously treated,relapsed breast cancer[J].J Clin Onco1,2000,18(11):2245-2249
5[1]Blackstein M,Vogel CL,Ambinder R,et al.Gemcitabine as first-line therapy in patinets with metastatic breast cancer a phase Ⅱ trail[J].Oncology,2002,62(1):2-8
6[2]Heinemann V.Gemcitabine plus cisplatin for the treatment of metastatic breast cancer[J].Clin Breast Cancer,2002,62 (1):2-8
7[3]Spiellmen M,Lombart cussac,Kalla S,et al.Single agent gemcitabine is active in previously treated metastaic breast cancer[J].Oncology,2001,60:303-307
8[4]Moorsel CJAV,Veeman G,Bergman AM,et al.Combination chemotherapy studies with gemcitabine[J].Semin Oncl,1997,24(17):17
9[5]Nagoumey RA.Gemeitabine plus cisplatin in breast cancer[J].Ontology (Hunting),2001,15(2):28-33
10Jemal A,Taylor T,Samuels A,et al Cancer statistics[J].CA Cancer J Clin,2003,53:5-26.
